BEONE MEDICINES LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
BEONE MEDICINES LTD. (ONC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.53 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-26
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.53M shares, a 72.47% decline from fiscal 2024.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 9.18M shares, a 6.49% decline from fiscal 2023.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 9.82M shares, a 21.56% decline from fiscal 2022.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 12.52M shares, a 100.44% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2025-12-31 | 2.53M shares 10-K · filed 2026-02-26 |
| 2024-12-31 | 9.18M shares 10-K · filed 2025-02-27 |
| 2023-12-31 | 9.82M shares 10-K · filed 2025-02-27 |
| 2022-12-31 | 12.52M shares 10-K · filed 2025-02-27 |
| 2021-12-31 | 6.24M shares 10-K · filed 2024-02-26 |
| 2020-12-31 | 9.00M shares 10-K · filed 2023-02-27 |
| 2019-12-31 | 12.64M shares 10-K · filed 2022-02-28 |